BioNTech SE (BNTX) Short term Debt (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Short term Debt data on file, last reported at $409.4 million in Q4 2025.

• In Q4 2025, Short term Debt fell 73.46% year-over-year to $409.4 million; the TTM figure through Dec 2025 stood at $409.4 million (down 73.46% YoY), while the FY2025 annual figure was $397.4 million, down 74.24% from the prior year.
• Short term Debt eased to $409.4 million in Q4 2025, from $698.4 million in the prior quarter.
• Across five years, Short term Debt topped out at $11.1 billion in Q2 2022 and bottomed at $37.3 million in Q3 2022.
• A 5-year average of $1.1 billion and a median of $428.1 million in 2023 frame the typical range for Short term Debt.
• Annual changes were most pronounced in 2021 — Short term Debt surged 12451.18% — and 2023, when it plunged 98.3%.
• Year by year, Short term Debt stood at $1.4 billion in 2021, then slumped by 41.18% to $801.0 million in 2022, then tumbled by 44.23% to $446.7 million in 2023, then soared by 245.27% to $1.5 billion in 2024, then plunged by 73.46% to $409.4 million in 2025.
• The last three Short term Debt figures came in at $409.4 million (Q4 2025), $698.4 million (Q3 2025), and $164.1 million (Q2 2025), per Business Quant data.

Peer Comparison